Merrimack Pharmaceuticals Inc. sell StockNews.com
Start price
08.07.23
/
50%
€3.98
Target price
08.07.24
-
Performance (%)
-
End price
09.07.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merrimack Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | -0,48 % | -12,06 % | -2,95 % |
| iShares Nasdaq 100 | -3,38 % | -5,13 % | 9,58 % |
| iShares Nikkei 225® | -0,14 % | -12,63 % | 20,32 % |
| iShares S&P 500 | -2,27 % | -5,05 % | 5,80 % |
Comments by StockNews_com for this prediction
In the thread Merrimack Pharmaceuticals Inc. diskutieren
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for MACK provided by MarketBeat
In the thread Trading Merrimack Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Merrimack Pharmaceuticals Inc.
Merrimack Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.98
24.06.23
24.06.23
-
24.06.24
24.06.24
-
25.06.24
25.06.24
